93 related articles for article (PubMed ID: 8060031)
1. Model parameter estimation and analysis: understanding parametric structure.
Li H; Watanabe K; Auslander D; Spear RC
Ann Biomed Eng; 1994; 22(1):97-111. PubMed ID: 8060031
[TBL] [Abstract][Full Text] [Related]
2. Incorporating Monte Carlo simulation into physiologically based pharmacokinetic models using advanced continuous simulation language (ACSL): a computational method.
Thomas RS; Lytle WE; Keefe TJ; Constan AA; Yang RS
Fundam Appl Toxicol; 1996 May; 31(1):19-28. PubMed ID: 8998950
[TBL] [Abstract][Full Text] [Related]
3. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
4. Modeling benzene pharmacokinetics across three sets of animal data: parametric sensitivity and risk implications.
Spear RC; Bois FY; Woodruff T; Auslander D; Parker J; Selvin S
Risk Anal; 1991 Dec; 11(4):641-54. PubMed ID: 1780503
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three physiologically based pharmacokinetic models of benzene disposition.
Bois FY; Woodruff TJ; Spear RC
Toxicol Appl Pharmacol; 1991 Aug; 110(1):79-88. PubMed ID: 1871774
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous estimation and segmentation from projection data in dynamic PET.
Cui J; Yu H; Chen S; Chen Y; Liu H
Med Phys; 2019 Mar; 46(3):1245-1259. PubMed ID: 30593666
[TBL] [Abstract][Full Text] [Related]
7. Quantifying the uncertainty in model parameters using Gaussian process-based Markov chain Monte Carlo in cardiac electrophysiology.
Dhamala J; Arevalo HJ; Sapp J; Horácek BM; Wu KC; Trayanova NA; Wang L
Med Image Anal; 2018 Aug; 48():43-57. PubMed ID: 29843078
[TBL] [Abstract][Full Text] [Related]
8. Structure and parameterization of pharmacokinetic models: their impact on model predictions.
Woodruff TJ; Bois FY; Auslander D; Spear RC
Risk Anal; 1992 Jun; 12(2):189-201. PubMed ID: 1502372
[TBL] [Abstract][Full Text] [Related]
9. Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach.
Yokley K; Tran HT; Pekari K; Rappaport S; Riihimaki V; Rothman N; Waidyanatha S; Schlosser PM
Risk Anal; 2006 Aug; 26(4):925-43. PubMed ID: 16948686
[TBL] [Abstract][Full Text] [Related]
10. [Effects of multiple-trough sampling design and algorithm on the estimation of population and individual pharmacokinetic parameters].
Ling J; Qian LX; Ding JJ; Jiao Z
Yao Xue Xue Bao; 2014 May; 49(5):686-94. PubMed ID: 25151742
[TBL] [Abstract][Full Text] [Related]
11. Accelerating Monte Carlo power studies through parametric power estimation.
Ueckert S; Karlsson MO; Hooker AC
J Pharmacokinet Pharmacodyn; 2016 Apr; 43(2):223-34. PubMed ID: 26934878
[TBL] [Abstract][Full Text] [Related]
12. Fast parametric imaging algorithm for dual-input biomedical system parameter estimation.
Choi HC; Chen S; Feng D; Wong KP
Comput Methods Programs Biomed; 2006 Jan; 81(1):49-55. PubMed ID: 16376452
[TBL] [Abstract][Full Text] [Related]
13. Estimation of interindividual pharmacokinetic variability factor for inhaled volatile organic chemicals using a probability-bounds approach.
Nong A; Krishnan K
Regul Toxicol Pharmacol; 2007 Jun; 48(1):93-101. PubMed ID: 17367907
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the nonparametric estimation method in NONMEM VI.
Savic RM; Kjellsson MC; Karlsson MO
Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
[TBL] [Abstract][Full Text] [Related]
15. Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results.
Spear RC; Bois FY
Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):61-6. PubMed ID: 7737043
[TBL] [Abstract][Full Text] [Related]
16. Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis.
Cox LA
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1413-29. PubMed ID: 9118928
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method.
Wang J; Liang WQ; Wu JJ; Pan CM
Acta Pharmacol Sin; 2000 Oct; 21(10):954-60. PubMed ID: 11501052
[TBL] [Abstract][Full Text] [Related]
18. Quality and precision of parametric images created from PET sinogram data by direct reconstruction: proof of concept.
Kamasak ME; Christian BT; Bouman CA; Morris ED
IEEE Trans Med Imaging; 2014 Mar; 33(3):695-707. PubMed ID: 24595343
[TBL] [Abstract][Full Text] [Related]
19. Optimization issues in physiological toxicokinetic modeling: a case study with benzene.
Woodruff TJ; Bois FY
Toxicol Lett; 1993 Aug; 69(2):181-96. PubMed ID: 8212060
[TBL] [Abstract][Full Text] [Related]
20. Inhalation exposure or body burden? Better way of estimating risk--An application of PBPK model.
Majumdar D; Dutta C; Sen S
Environ Toxicol Pharmacol; 2016 Jan; 41():54-61. PubMed ID: 26650798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
